Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-12-17 Sale |
2020-12-18 4:29 pm |
Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director |
88,764 | $53.55 | $4,753,680 | 5,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-07-19 Option Award |
2023-07-21 5:10 pm |
N/A 2033-07-18 |
Graphite Bio Inc. | GRPH | KARSEN PERRY A Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2023-05-03 Equity Swap |
2023-05-04 07:44 am |
N/A N/A |
Jounce Therapeutics Inc. | JNCE | KARSEN PERRY A Director |
5,000 | $0 | 0 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-28 9:07 pm |
N/A 2032-06-24 |
Jounce Therapeutics Inc. | JNCE | KARSEN PERRY A Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-06-21 Option Award |
2022-06-22 5:38 pm |
N/A 2032-06-20 |
Graphite Bio Inc. | GRPH | KARSEN PERRY A Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-03-11 Option Award |
2021-07-01 7:00 pm |
N/A N/A |
Graphite Bio Inc. | GRPH | KARSEN PERRY A Director |
19,763 | $5.06 | 277,289 (Direct) |
View |
| 2021-06-29 Conversion |
2021-07-01 7:00 pm |
N/A N/A |
Graphite Bio Inc. | GRPH | KARSEN PERRY A Director |
27,889 | $0 | 277,289 (Direct) |
View |
| 2021-01-13 Option Award |
2021-07-01 7:00 pm |
N/A 2031-01-12 |
Graphite Bio Inc. | GRPH | KARSEN PERRY A Director |
93,492 | $0 | 277,289 (Direct) |
View |
Ownership |
2021-06-24 9:14 pm |
N/A N/A |
Graphite Bio Inc. | GRPH | KARSEN PERRY A Director |
0 | $0 | 257,526 (Direct) |
View |
| 2021-06-18 Option Award |
2021-06-22 4:34 pm |
N/A 2031-06-18 |
Jounce Therapeutics Inc. | JNCE | KARSEN PERRY A Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-18 4:29 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director |
19,000 | $14.35 | 5,000 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-18 4:29 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director |
19,000 | $15.78 | 5,000 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-18 4:29 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director |
31,764 | $18 | 5,000 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-18 4:29 pm |
N/A N/A |
Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director |
19,000 | $25.98 | 5,000 (Direct) |
View |
| 2020-12-17 Exercise |
2020-12-18 4:29 pm |
N/A 2026-05-04 |
Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director |
88,764 | $0 | 5,000 (Direct) |
View |
Ownership |
2020-11-18 8:06 pm |
N/A N/A |
Jiya Acquisition Corp. | JYAC | KARSEN PERRY A Director |
0 | $0 | 30,000 (Direct) |
View |
| 2020-06-26 Option Award(A) |
2020-07-02 7:35 pm |
N/A 2030-06-26 |
Jounce Therapeutics Inc. | JNCE | KARSEN PERRY A Director |
15,700 | $0 | 15,700 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-29 7:34 pm |
N/A 2030-06-26 |
Jounce Therapeutics Inc. | JNCE | KARSEN PERRY A Director |
13,550 | $0 | 13,550 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-19 4:46 pm |
N/A 2030-06-17 |
Intellia Therapeutics Inc. | NTLA | KARSEN PERRY A Director |
19,000 | $0 | 19,000 (Direct) |
View |